Timonacic is primarily used in research settings for its ability to modulate enzyme activity, particularly in studies related to nucleoside metabolism. It has been investigated for its potential to enhance the efficacy of certain antiviral and anticancer agents by inhibiting enzymes that degrade therapeutic nucleoside analogs. This action helps prolong the activity of these drugs in the body, potentially improving treatment outcomes. Due to its role in metabolic stabilization, Timonacic has been explored in combination therapies, especially in oncology, where maintaining active drug concentrations is critical. Its application remains largely experimental and is not approved for clinical use in most countries.